OrbiMed’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$68.6M Buy
2021
Q2
$84M Sell
2021
Q1
$67.3M Buy
2020
Q4
$69.2M Sell
2020
Q3
$52.7M Sell
2020
Q2
$51.3M Buy
2020
Q1
$23.4M Sell
2019
Q4
$46.7M Buy
2019
Q3
$21.2M Buy
2018
Q4
Sell
2018
Q3
$22M Hold
2018
Q2
$29.2M Buy
2018
Q1
$4.77M Buy
2017
Q4
Sell
2017
Q3
$6.65M Hold
2017
Q2
$5.96M Hold
2017
Q1
$8.1M Hold
2016
Q4
$7.54M Buy